MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.
Matt Garman took the helm at Amazon Web Services (AWS), the cloud computing arm of the U.S. tech giant, in June, but he ...
In general, Amazon's approach is to be everything to everyone rather than striving for a niche audience, and it has released ...
Shares of Amazon (NASDAQ: AMZN) slipped as investors were disappointed with the company's first-quarter revenue forecast.
Is Amazon's (NASDAQ: AMZN) remarkable growth story fizzling? At first glance, one might think so. Management's guidance ...
The tech giant's ad revenue grew by 18 percent in its latest quarter, as did overall sales and operating income.
The expected $100 billion annual capex, up from $83 billion last year, also includes e-commerce warehouses and offices.
As Amazon continues heavy investment in AI infrastructure, the company's CEO said the AI business is growing at a ...
AMZN shares seem pricey compared to other Magnificent 7 stocks, following a 40% stock price increase over the past year.
Amazon (AMZN) is going all-in on artificial intelligence, planning to pour over $100 billion into AI infrastructure in 2025.
Amazon’s net sales increased 10% to $187.8 billion in the fourth quarter, compared with $170 billion in the prior year period ...